Report #2835252

Overview

Sex

Female

Age

Age unknown

State

—

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (3)

Symptom narrative

no smell; no taste; no balance; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A female patient received BNT162b2 (BNT162B2 NOS), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "multiple sclerosis" (ongoing); "cholesterol" (unspecified if ongoing). Concomitant medication(s) included: COLESTID taken for blood cholesterol abnormal. Vaccination history included: Bnt162b2 (dose 1, single), for covid-19 immunization, reaction(s): "no taste", "no smell", "no balance"; Bnt162b2 (dose 2, single), for covid-19 immunization, reaction(s): "no taste", "no smell", "no balance". The following information was reported: ANOSMIA (non-serious), outcome "unknown", described as "no smell"; AGEUSIA (non-serious), outcome "unknown", described as "no taste"; BALANCE DISORDER (non-serious), outcome "unknown", described as "no balance". Additional information: The caller (patient) stated that she has multiple sclerosis and she had to take three shots of the Pfizer COVID vaccine because she was in the state of PRIVACY and she could not get them to check her blood thinner without taking the shots. She said that she had no smell, no taste, and no balance after taking them. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202500038008 Same patient/ product/ AEs, different doses.;US-PFIZER INC-202500069090 Same patient/ product/ AEs, different doses.;

Current illness

Multiple sclerosis

Medical history

Medical History/Concurrent Conditions: Blood cholesterol abnormal

Other medications

COLESTID